Fu Yanhua, Xiao Yuanyuan, Gao Tianji, Zhang Junxiu, Wang Tianjiao
Department of Rheumatology, Baoding Hospital of Beijing Children's Hospital, Baoding, 071000, People's Republic of China.
Department of Dermatology, National Center for Children's Health (Beijing) Children's Hospital Affiliated to Capital Medical University, Beijing, 100045, People's Republic of China.
Clin Cosmet Investig Dermatol. 2024 Jan 23;17:167-171. doi: 10.2147/CCID.S440476. eCollection 2024.
Toxic epidermal necrolysis (TEN) is a type of drug eruption in dermatology emergencies that is rare in clinical practice but has a high mortality rate. The main causes are drug and viral infections. Unfortunately, no expert consensus on treating this disease exists, and a standard therapy is absent. Up to now, glucocorticoids combined with gamma globulin are commonly used in clinical practice, but their efficacy is highly controversial. This study reports on a 7-year-old girl with TEN who did not respond to traditional therapy, such as methylprednisolone combined with gamma globulin, but was finally cured with an additional low-dose etanercept. The results showed that etanercept therapy in paediatric TEN is safe, reliable and worth recommending.
中毒性表皮坏死松解症(TEN)是皮肤科急症中的一种药疹,临床实践中较为罕见,但死亡率很高。主要病因是药物和病毒感染。遗憾的是,目前尚无关于该病治疗的专家共识,也没有标准疗法。到目前为止,糖皮质激素联合丙种球蛋白在临床实践中常用,但它们的疗效极具争议。本研究报告了一名7岁患中毒性表皮坏死松解症的女孩,她对传统疗法如甲泼尼龙联合丙种球蛋白没有反应,但最终通过加用低剂量的依那西普治愈。结果表明,依那西普治疗儿童中毒性表皮坏死松解症安全、可靠,值得推荐。